BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Alphatec Spine Announces Date for Second Quarter 2012 Financial Results

  July 24, 2012

   · 

  1 min read
• Business

  AtriCure, Inc. to Announce Second Quarter 2012 Financial Results

  July 24, 2012

   · 

  1 min read
• Business

  Victor Ambros Joins Firefly BioWorks’ Scientific Advisory Board

  July 24, 2012

   · 

  1 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Release: Vosaroxin Review Published in Expert Opinion on Investigational Drugs

  July 24, 2012

   · 

  1 min read
• Drug Development

  NeurogesX, Inc. Partner Astellas Pharma Inc. Enrolls First Patient in EU Clinical Trial for QUTENZA(R) (8% Capsaicin Patch)

  July 24, 2012

   · 

  1 min read
• Drug Development

  XenoPort, Inc. Announces Initiation of a Phase 1 Clinical Trial of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis

  July 24, 2012

   · 

  1 min read
• Business

  Major Medical Institution Turns to OnPoint Medical Diagnostics for MRI Quality Assurance

  July 24, 2012

   · 

  1 min read
• Business

  Source BioScience Trading Update for the Six Months Ended 30 June 2012

  July 24, 2012

   · 

  4 min read
• Oxford Gene Technology Ltd. Awarded €3 Million From Prestigious EU Clinical Research Grants

  July 24, 2012

   · 

  6 min read
• Policy

  PerkinElmer, Inc. Receives State of Connecticut Clinical Laboratory Licensure and CLIA Certificate of Registration for Global DNA Sequencing Services

  July 24, 2012

   · 

  1 min read